Millie Das, MD

Thoracic Oncologist, Clinical Professor

in Oncology at Stanford University, CA

Chief, Department of Oncology in Palo

Alto VA Medical Center, CA

Martin Dietrich, MD, PhD

Medical Oncologist, Cancer Care

Centers of Brevard, FL

Internal Medicine Professor at

University of Central Florida, FL

Review and discuss the clinical implications of the five-year outcomes with first-line nivolumab + ipilimumab with chemotherapy vs chemotherapy in patients with metastatic NSCLC in CheckMate 9LA

© 2025 Bristol-Myers Squibb Company.

OPDIVO^® is a registered trademark of Bristol-Myers Squibb Company.